Ideally, IHC is required for breast carcinoma typing performed by cell staining with biomarkers such as hormone receptor (progesterone receptor (PR) and estrogen receptor (ER)) as well as human epidermal growth factor receptor two (HER2) markers [50]. Here, ERBB2 is linked to breast carcinoma.